Semaglutide Solid-Phase Synthesis Managing Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of semaglutide is challenging due to aggregation tendencies, unwanted side reactions, and issues with racemization and peptide yield and purity, especially when introducing complex side chain substituents.
Innovation Solution
A method for the complete solid-phase synthesis of semaglutide is developed, involving the stepwise solid-phase peptide synthesis (SPPS) with specific protecting groups and coupling strategies to manage aggregation and ensure high yield and purity, including the use of pseudoproline dipeptide derivatives to suppress peptide aggregation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If side-chain amino groups are acylated to modify peptide properties, then stability against enzymatic degradation and circulation lifetime are improved, but unwanted side reactions and racemization occur reducing yield and purity
Solution Approach 1:
The patent applies preliminary anti-action by using specific protecting groups (Alloc for side-chain amino groups, Fmoc for alpha amino groups) and coupling agents (HATU, HBTU) before the acylation reaction to prevent unwanted side reactions and racemization. The protecting groups are strategically selected to remain stable during acylation but can be removed selectively later, thus preventing harmful side reactions in advance while enabling the desired modification.
Solution Approach 2:
The patent uses coupling agents (HATU, HBTU) as intermediaries to facilitate the acylation reaction. These coupling agents mediate between the acylating agent and the side-chain amino group, enabling the modification to proceed efficiently while minimizing side reactions and racemization. The intermediaries control the reaction pathway to achieve high yield and purity.
2Adaptability or versatility
If complex side chain substituents are introduced through acylation, then peptide functionality is enhanced, but aggregation tendencies increase leading to reduced synthesis efficiency
Solution Approach 1:
The patent applies parameter changes by carefully selecting and optimizing reaction conditions including solvent composition (DMF, DCM), temperature control, and stoichiometry of reagents. These parameter adjustments prevent aggregation of the peptide chain during acylation, maintaining synthesis efficiency while enabling the introduction of complex side chain substituents that enhance peptide functionality.
Solution Approach 2:
The patent uses specific protecting groups and coupling agents as intermediaries that prevent aggregation during the acylation process. The Alloc and Fmoc protecting groups, combined with coupling agents like HATU and HBTU, mediate the reaction to proceed smoothly without causing aggregation, thus maintaining high productivity while introducing complex functional substituents.
3Ease of manufacture
If solid-phase peptide synthesis is used to ensure ease of purification, then intermediate isolation is simplified, but complete synthesis of semaglutide with complex modifications becomes challenging
Solution Approach 1:
The patent applies segmentation by dividing the synthesis into distinct stages: first synthesizing the peptide backbone on solid phase using standard SPPS with Fmoc-protected amino acids, then performing the acylation modification on the resin-bound intermediate. This segmentation allows the benefits of solid-phase synthesis (easy purification) to be retained while accommodating complex modifications through sequential reaction steps.
Solution Approach 2:
The patent uses preliminary action by pre-synthesizing the peptide chain on solid phase with appropriate protecting groups in place before introducing the complex acylated side chain. The Alloc-protected Lysine residue is incorporated during standard SPPS, and the acylation is performed as a subsequent step on the resin-bound intermediate, thus preparing the molecule in advance for the complex modification while maintaining purification advantages.
Data Source
AI summary
The present invention relates to methods and compounds for the solid phase synthesis of peptides carrying a substituent at an amino group of an amino acid side chain.